Latest Headlines

  1. Illumina Whole-Genome Sequencing Technology To Accelerate Rare Disease Testing In Florida 2/27/2026

    Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases.

  2. ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation For Biotechnology And Pharmaceutical Partners 2/26/2026

    ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners.

  3. Thermo Fisher Scientific Introduces New Laboratory Developed Test To Help Transplant Patients Receive The Right Dose Of Critical Anti-Rejection Medication Sooner 2/26/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection.

  4. 20/20 BioLabs Launches OneTest For Longevity Blood Test And Chronic Disease Risk Assessment And Management Solution Built With IBM AI Capabilities 2/25/2026

    20/20 BioLabs (Nasdaq: AIDX), an early market leader in cutting-edge, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announces the launch and commercial availability of its OneTest for Longevity solution.

  5. Ultima Genomics And Hamilton Partner To Automate Sample Preparation And Amplification Workflows For The Ultima Family Of Sequencing Systems To Enable Improved Lab Operations And Drive Sequencing At Scale 2/25/2026

    Ultima Genomics, a developer of ultra-high-throughput sequencing systems, together with Hamilton (Hamilton Company and Hamilton Bonaduz AG), a global leader in precision laboratory automation, today announced a partnership to automate Ultima's latest sample preparation and amplification technology across Hamilton's Microlab® STAR™ liquid handling platform.

  6. Illumina Launches TruPath Genome, Setting A New Standard In Genomic Insight 2/24/2026

    Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease.

  7. Epredia And Mindpeak Announce EU Distribution Agreement For AI-Powered Image Recognition In Cancer Diagnostics 2/24/2026

    Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation and Mindpeak, a leading provider of artificial intelligence (AI) solutions for clinical and research pathology, today announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.

  8. Rapid And Accurate Method From VTT For Detecting Hormones, Toxins And Other Small Molecules 2/24/2026

    In the field of diagnostics, there has long been a search for solutions to measure low concentrations of small molecules accurately, quickly and easily, for example from food, the environment or a patient sample.

  9. ClearNote Health's Enhanced Avantect Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance 2/23/2026

    ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the availability of its enhanced Avantect Pancreatic Cancer Test, which delivers significantly improved detection for patients at elevated risk of this disease.

  10. BD Expands Testing Capabilities To Help Clinicians Improve Diagnostic Accuracy And Efficiency 2/23/2026

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Vacutainer® Urine Complete Cup Kit, a three-tube collection system that expands and supports broader testing capabilities from a single urine specimen.